Talk:Forkhead box protein O1

Wiki Education Foundation-supported course assignment

This article is or was the subject of a Wiki Education Foundation-supported course assignment. Further details are available on the course page. Student editor(s): Dimah Almahbub. Peer reviewers: Ddoerflinger, SSASHWIN, KP 0503.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 21:41, 16 January 2022 (UTC)

Bibliography List

I planed to contribute in update this article FOXO1 and Here a list of bibliography that I'm working on.

• Gross DN, van den Heuvel AP, Birnbaum MJ (2008). "The role of FoxO in the regulation of metabolism". Oncogene. 27 (16): 2320–36. doi:10.1038/onc.2008.25. PMID 18391974.
• Hedrick SM, Hess Michelini R, Doedens AL, Goldrath AW, Stone EL (2012). "FOXO transcription factors throughout T cell biology". Nature Reviews. Immunology. 12 (9): 649–61. doi:10.1038/nri3278. PMC 3875397. PMID 22918467.
• Lu H, Huang H (2011). "FOXO1: a potential target for human diseases". Current Drug Targets. 12 (9): 1235–44. doi:10.2174/138945011796150280. PMC 4591039. PMID 21443466.
• Wang Y, Zhou Y, Graves DT (2014). "FOXO transcription factors: their clinical significance and regulation". BioMed Research International. 2014: 925350. doi:10.1155/2014/925350. PMC 4016844. PMID 24864265.{{cite journal}}: CS1 maint: unflagged free DOI (link)

— Preceding unsigned comment added by Dimah Almahbub (talk • contribs) 02:56, 19 February 2017 (UTC)

Looks good. All reviews. There are a couple of more recent reviews that you might also consider:

• Pandey A, Kumar GS, Kadakol A, Malek V, Gaikwad AB (2016). "FoxO1 Inhibitors: The Future Medicine for Metabolic Disorders?". Current Diabetes Reviews. 12 (3): 223–30. doi:10.2174/1573399811666150804104858. PMID 26239835.
• Xiao E, Graves DT (2015). "Impact of Diabetes on the Protective Role of FOXO1 in Wound Healing". Journal of Dental Research. 94 (8): 1025–6. doi:10.1177/0022034515586353. PMC 4530387. PMID 25978971.
• Hameedaldeen A, Liu J, Batres A, Graves GS, Graves DT (2014). "FOXO1, TGF-β regulation and wound healing". International Journal of Molecular Sciences. 15 (9): 16257–69. doi:10.3390/ijms150916257. PMC 4200873. PMID 25226535.{{cite journal}}: CS1 maint: unflagged free DOI (link)
• Lettieri Barbato D, Aquilano K, Ciriolo MR (2014). "FoxO1 at the nexus between fat catabolism and longevity pathways". Biochimica et Biophysica Acta. 1841 (10): 1555–1560. doi:10.1016/j.bbalip.2014.08.004. PMID 25135341.
• Szydłowski M, Jabłońska E, Juszczyński P (2014). "FOXO1 transcription factor: a critical effector of the PI3K-AKT axis in B-cell development". International Reviews of Immunology. 33 (2): 146–57. doi:10.3109/08830185.2014.885022. PMID 24552152.

Boghog (talk) 07:12, 19 February 2017 (UTC)

Regulation of lifespan by neural excitation and REST

A key quote from the Zullo et al paper is REST, SPR-3, SPR-4 and reduced excitation activate the longevity-associated transcription factors FOXO1 and DAF-16 in mammals and worms, respectively. It seems to me that the association of FOXO1 & reduced excitation of neurons is entirely missing from this article. Here are relevant articles on this finding, the first two of which are available via the Wikipedia Library.

• Tavernarakis, Nektarios (2019-10-16). "Moderation of neural excitation promotes longevity". Nature. 574 (7778). Springer Science and Business Media LLC: 338–340. doi:10.1038/d41586-019-02958-x. ISSN 0028-0836.
• Zullo, Joseph M.; Drake, Derek; Aron, Liviu; O’Hern, Patrick; Dhamne, Sameer C.; Davidsohn, Noah; Mao, Chai-An; Klein, William H.; Rotenberg, Alexander; Bennett, David A.; Church, George M.; Colaiácovo, Monica P.; Yankner, Bruce A. (2019-10-16). "Regulation of lifespan by neural excitation and REST". Nature. 574 (7778). Springer Science and Business Media LLC: 359–364. doi:10.1038/s41586-019-1647-8. ISSN 0028-0836.
• Greenwood, Veronique (2019-11-26). "Longevity Linked to Proteins That Calm Overexcited Neurons". Quanta Magazine.

Peaceray (talk) 19:20, 30 September 2022 (UTC)